Catheter Precision Inc. [AMEX: VTAK] closed the trading session at $0.44.
The stocks have a year to date performance of -89.10 percent and weekly performance of 24.16 percent. The stock has been moved at -90.84 percent over the last six months. The stock has performed -1.63 percent around the most recent 30 days and changed -83.68 percent over the most recent 3-months.
If compared to the average trading volume of 243.28K shares, VTAK reached to a volume of 8677191 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Catheter Precision Inc. [VTAK]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VTAK shares is $41.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VTAK stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Jaffray have made an estimate for Catheter Precision Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 13, 2019. While these analysts kept the previous recommendation, Maxim Group raised their target price to Buy. The new note on the price target was released on November 02, 2018, representing the official price target for Catheter Precision Inc. stock.
The Average True Range (ATR) for Catheter Precision Inc. is set at 0.08, with the Price to Sales ratio for VTAK stock in the period of the last 12 months amounting to 2.80. The Price to Book ratio for the last quarter was 0.02, with the Price to Cash per share for the same quarter was set at 0.01.
VTAK stock trade performance evaluation
Catheter Precision Inc. [VTAK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 24.16. With this latest performance, VTAK shares dropped by -1.63% in over the last four-week period, additionally sinking by -90.84% over the last 6 months – not to mention a drop of -88.45% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VTAK stock in for the last two-week period is set at 40.97, with the RSI for the last a single of trading hit 56.71, and the three-weeks RSI is set at 35.43 for Catheter Precision Inc. [VTAK]. The present Moving Average for the last 50 days of trading for this stock 0.8304, while it was recorded at 0.3889 for the last single week of trading, and 3.6587 for the last 200 days.
Catheter Precision Inc. [VTAK]: An insightful look at the core fundamentals
Catheter Precision Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.10 and a Current Ratio set at 0.12.
Earnings per share (EPS) analysis for Catheter Precision Inc. [VTAK] stock
With the latest financial reports released by the company, Catheter Precision Inc. posted -11.5/share EPS, while the average EPS was predicted by analysts to be reported at -3.02/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -8.48. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VTAK.
Catheter Precision Inc. [VTAK]: Institutional Ownership
There are presently around $2.53%, or 3.04%% of VTAK stock, in the hands of institutional investors.
